scispace - formally typeset
I

Isabel M. McFarlane

Researcher at State University of New York System

Publications -  86
Citations -  538

Isabel M. McFarlane is an academic researcher from State University of New York System. The author has contributed to research in topics: Population & Myocardial infarction. The author has an hindex of 7, co-authored 78 publications receiving 280 citations. Previous affiliations of Isabel M. McFarlane include SUNY Downstate Medical Center.

Papers
More filters
Journal ArticleDOI

Gastrointestinal Manifestations of Systemic Sclerosis

TL;DR: The current understanding of the pathophysiologic mechanisms of SSc including vasculopathy, endothelial to mesenchymal transformation as well as the autoimmune pathogenetic pathways are presented.
Journal ArticleDOI

A Systematic Review of COVID-19 and Myocarditis

TL;DR: Clinical features of myocarditis in patients infected with COVID-19 patients revealed reduced left ventricular ejection fraction with cardiomegaly or increased wall thickness, while laboratory tests revealed leukocytosis with increased C-reactive protein.

Inflammation beyond the Joints: Rheumatoid Arthritis and Cardiovascular Disease.

TL;DR: The epidemiology of CVD in RA populations, the underlying pathophysiologic mechanisms of CVC in RA including the role of chronic inflammation in driving accelerated atherosclerosis, the obesity paradox and altered metabolic pathways leading to pro-inflammatory HDL formation and insulin resistance are discussed.
Journal ArticleDOI

Ocular Manifestations of Rheumatoid Arthritis: Implications of Recent Clinical Trials

TL;DR: The current understanding of the pathophysiologic mechanisms for ocular disease in RA is presented, including the role of oxidative stress, cytokine imbalance, chronic inflammation, vascular permeability, immune complex deposition and the roles of T-cells as well as the contribution of tear hyperosmolarity among other factors.
Journal ArticleDOI

Community-Acquired Pneumonia: A Focused Review

TL;DR: A review of the epidemiology, pathophysiology, risk factors, symptoms, diagnosis, presentations, risk-stratification, markers, and management of community-acquired pneumonia in the United States (US) is presented.